Atea Pharmaceuticals AVIR
NASDAQ AVIR
$5.22 +0.04 (+0.68%)
As of: Sep 30, 2026 · 3:59 PM EDT

Atea Pharmaceuticals (AVIR) Net Margin (2021)

Updated

Atea Pharmaceuticals (AVIR) reported Net Margin of 60.95% for Q4 2021, up 146.88 percentage points from the prior quarter.

Analysis

Atea Pharmaceuticals (AVIR) Net Margin (2021) Analysis & Trends

For FY2021, Atea Pharmaceuticals posted Net Margin of 34.49%, up 57.00 percentage points from FY2020.

  • By year, Net Margin came in at -22.51% in FY2020.
  • Per Business Quant data, the three quarters before Q4 2021 came in at -85.93% (Q3 2021), 2.55% (Q2 2021) and 46.55% (Q1 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 21.86%
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 21.27%
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -8.04%
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 22.61%
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 18.81%
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 23.62%
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -134.51%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -1.65%
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 32.99%
10 Atea Pharmaceuticals 415.46 Mn 415.46 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 60.95%
Sep 30, 2021 -85.93%
Jun 30, 2021 2.55%
Mar 31, 2021 46.55%
API Access

Atea Pharmaceuticals Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=AVIR&period=max&api_key=YOUR_API_KEY